Nuveen Asset Management, LLC Oyster Point Pharma, Inc. Transaction History

Nuveen Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.6 - $11.2 $386,467 - $1.2 Million	-107,352 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.58 - $17.65 $467,155 - $960,989	54,447 Added 102.91%	107,352 $1.25 Million
Q4 2021 Feb 14, 2022	SELL	$10.17 - $18.96 $61,823 - $115,257	-6,079 Reduced 10.31%	52,905 $672,000
Q3 2021 Nov 12, 2021	SELL	$11.67 - $18.07 $21,787 - $33,736	-1,867 Reduced 3.07%	58,984 $773,000
Q2 2021 Aug 16, 2021	BUY	$16.25 - $21.51 $182,763 - $241,922	11,247 Added 22.67%	60,851 $1.05 Million
Q1 2021 May 17, 2021	BUY	$17.92 - $25.86 $99,061 - $142,954	5,528 Added 12.54%	49,604 $907,000
Q4 2020 Feb 16, 2021	BUY	$18.13 - $25.18 $160,704 - $223,195	8,864 Added 25.17%	44,076 $829,000
Q3 2020 Nov 16, 2020	BUY	$17.83 - $29.12 $189,711 - $309,836	10,640 Added 43.3%	35,212 $743,000
Q2 2020 Aug 14, 2020	BUY	$27.86 - $35.93 $315,709 - $407,158	11,332 Added 85.59%	24,572 $709,000
Q1 2020 May 14, 2020	BUY	$23.65 - $40.96 $313,126 - $542,310	13,240 New	13,240 $463,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.